Latest news
Iconovo mentioned in Biostock (only in Swedish)
Starkt första kvartal för Iconovo
Inhalationsbolaget Iconovos första kvartal 2019 kan väsentligen sammanfattas med en större bokförd intäktspost,…
Annual Report 2018 (only in Swedish)
Årsredovisning 2018
Nu finns Årsredovisningen inklusive revisionsberättelse för Iconovo AB tillgänglig för 2018 (only in Swedish).
Press releases
Apr 28, 2023, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
mfn-cus-disclaimer
Apr 20, 2023, 10:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Apr 14, 2023, 08:45
News
IR
Swedish
Corporate Action
Other
Apr 14, 2023, 08:45
News
IR
English
Corporate Action
Other
Apr 04, 2023, 08:15
News
IR
English
Regulatory
MAR
Corporate Action
Other
Apr 04, 2023, 08:15
News
IR
Swedish
Regulatory
MAR
Corporate Action
Other
Mar 31, 2023, 10:01
News
IR
Swedish
Corporate Information
Other Corporate Information
Mar 16, 2023, 14:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Feb 10, 2023, 11:20
News
IR
Swedish
Corporate Information
Other Corporate Information
Feb 09, 2023, 15:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Feb 08, 2023, 23:59
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
Feb 08, 2023, 23:59
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
Feb 08, 2023, 17:32
News
IR
English
Regulatory
MAR
Report
Interim
Yearend
Feb 08, 2023, 17:32
News
IR
Swedish
Regulatory
MAR
Report
Interim
Yearend
Feb 08, 2023, 17:31
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
Feb 08, 2023, 17:31
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
Feb 03, 2023, 08:30
News
IR
English
Corporate Information
Other Corporate Information
Feb 03, 2023, 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Jan 26, 2023, 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Jan 26, 2023, 08:30
News
IR
English
Corporate Information
Other Corporate Information
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
